Wall Street Rallies as Middle East Optimism Drives Dow to New Record
Este Lauder Shares Rise Premarket After Termination of Merger Talks with Puig
Automation May Reshape Garment Manufacturing Bringing TShirt Production Back to the West
Chime Reaches Milestone with First GAAP Profitable Quarter in Q1 2026 Revenue Hits 647 Million
ING Develops AIPowered Trading System in Hours Capturing Wall Streets Attention
US Natural Gas Futures Decline as Forecasts Shift Warmer for Early February
Sagimet Biosciences Inc Q1 2026 Earnings Narrowed Loss Beats Expectations as Clinical Pipeline Advances
RDWR Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction
iQIYI Q1 2026 Earnings EPS Misses Estimates as Profitability Challenges Persist
CPSH Q1 2026 Earnings EPS Misses Estimates Stock Rises Over 28
WBS Q1 2026 Earnings EPS Beats Estimates as Stock Edges Lower
BBLG Q1 2026 Earnings Narrowed Loss Beats Estimates as Bone Biologics Advances Pipeline
Edgewise Therapeutics EWTX Holds Steady Near Support Amid Biotech Trading Lull
Tenaya Therapeutics TNYA Slips 228 as Stock Tests Key Support at 073
Palisade Bio PALI Edges Higher as Shares Test Key Resistance Zone
Nexalin Technology NXL Slides 526 as Stock Tests Key Support at 036
Nurix Therapeutics Shares Dip Slightly Holds Above Key Support NRIX
Nvidia Earnings Call in Focus Potential Impact of USChina Chip Policy and Trump Tariffs on Market Sentiment
Citigroup Q1 2026 Earnings Strong EPS Beat of 133 Driven by Robust Investment Banking
Lightbridge Corporation LTBR Slides 267 as Stock Tests Key Support Zone
BTMD Q1 2026 Earnings EPS Beats Estimates Stock Rises 26
Atrium Therapeutics Inc RNA Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment
Deckers Outdoor DECK Q1 2026 Earnings Ugg and Hoka Drive DoubleDigit EPS Beat Revenue Details Withheld
ADAMZ Q1 2026 Earnings Strong EPS Beat of 75 Despite Flat Revenue and Share Price Dip
CARR Q1 2026 Earnings EPS Beats Estimates by Nearly 10 Stock Gains
AVTR Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 3
IMRX Q1 2026 Earnings EPS Beat Estimates by 183 as Clinical Pipeline Advances